Despite COVID-19, we are operating at full capacity and all project work is operating as usual.

Clinically predictive preclinical efficacy testing services at your disposal

Pharmatest Services Ltd attends EAU congress in Madrid

Pharmatest Services Ltd attends the European Association of Urology (EAU) congress held in Madrid, Spain on March 20 – 24, 2015. Pharmatest attends the event with two scientific presentations.

Pharmatest Services Ltd (Pharmatest) is a contract research organization that offers preclinical efficacy services for the pharmaceutical industry in the fields of oncology and skeletal diseases. EAU congress is Europe’s largest annual event in urology, with over 14,000 expected participants from more than 100 countries.

This year Pharmatest attends EAU with the following two scientific presentations that describe recent results from its R&D pipeline:

-       Presentation number 409: Promoting advanced prostate cancer drug development by clinically predictive models enhanced with novel patient-derived xenografts (PDX)

-       Presentation number 787: Norway spruce galactoglucomannan attenuates symptoms of nonbacterial chronic prostatitis/chronic pelvic pain syndrome in rat model

If you would like to meet our representatives during the EAU congress, click here.